CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.680
-0.090 (-1.89%)
At close: Mar 6, 2026, 4:00 PM EST
4.641
-0.039 (-0.84%)
After-hours: Mar 6, 2026, 7:40 PM EST
CytomX Therapeutics Employees
As of December 31, 2024, CytomX Therapeutics had 121 total employees, including 119 full-time and 2 part-time employees. The number of employees decreased by 1 or -0.82% compared to the previous year.
Employees
121
Change (1Y)
-1
Growth (1Y)
-0.82%
Revenue / Employee
$939,099
Profits / Employee
$231,554
Market Cap
792.96M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| KalVista Pharmaceuticals | 270 |
| Xencor | 250 |
| Omeros | 202 |
| Sana Biotechnology | 194 |
| Kura Oncology | 192 |
| Annexon | 99 |
CTMX News
- 3 days ago - CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - GlobeNewsWire
- 4 weeks ago - CytomX Therapeutics to Present at Upcoming February Conferences - GlobeNewsWire
- 5 weeks ago - Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development - GlobeNewsWire
- 6 weeks ago - Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics - Business Wire
- 7 weeks ago - CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - CytomX Therapeutics Announces Business Update and Company Milestones for 2026 - GlobeNewsWire
- 2 months ago - CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling - Seeking Alpha
- 3 months ago - CytomX Therapeutics to Present at Upcoming December Investor Conferences - GlobeNewsWire